A 45-year-old patient with atrial fibrillation is treated with amiodarone 400 mg/day and rivaroxaban 20mg/day with the evening meal. He has concern about his drugs routine monitoring.
Which of the following would be the best recommended regarding amiodarone monitoring?
A. Slit-lamp examination at baseline and annually
B. Renal function tests at baseline and annually
C. Cardiac enzymes at baseline and annually
D. Liver function tests at baseline and every 6 months
The correct answer is D. Liver function tests at baseline and every 6 months.
Explanation:
1. Amiodarone Monitoring Guidelines
Amiodarone is a highly effective Class III antiarrhythmic agent, but it is associated with significant organ toxicities due to its long half-life and tissue accumulation. Standard clinical guidelines (including ACC/AHA/HRS recommendations) mandate the following routine monitoring schedule:
Liver Function Tests (LFTs - AST, ALT, Bilirubin): Baseline, then every 6 months. (Amiodarone can cause hepatotoxicity, ranging from asymptomatic transaminase elevation to severe cirrhosis or hepatitis).
Thyroid Function Tests (TSH, Free T4): Baseline, then every 6 months. (Due to its high iodine content, amiodarone can induce both hypothyroidism and hyperthyroidism).
Chest X-ray & Pulmonary Function Tests (PFTs): Baseline, then annually or if pulmonary symptoms (cough, dyspnea) develop to monitor for pulmonary toxicity.
Electrocardiogram (ECG): Baseline, then every 3–6 months to monitor QTc interval prolongation and heart rate.
Why the Other Options Are Incorrect:
A. Slit-lamp examination at baseline and annually: Corneal microdeposits occur in almost all patients taking long-term amiodarone, but they are generally benign and asymptomatic. Regular ophthalmologic/slit-lamp evaluation is generally reserved for patients who experience visual symptoms (e.g., halos around lights, decreased visual acuity) or to evaluate for rare optic neuropathy, rather than as a routine annual screen for all patients.
B. Renal function tests at baseline and annually: Amiodarone is primarily metabolized by the liver and eliminated non-renally. Renal toxicity is not a primary adverse effect of amiodarone requiring routine interval monitoring compared to LFTs and TFTs.
C. Cardiac enzymes at baseline and annually: Cardiac enzymes (troponin, CK-MB) are used for diagnosing acute myocardial necrosis (heart attack), not for routine outpatient drug toxicity monitoring.
Exam pearl: Remember amiodarone → thyroid and liver function tests at baseline and every 6 months. Also monitor for pulmonary toxicity, bradycardia, QT prolongation, and clinically significant drug interactions.
A 30-year-old woman with a history of deep vein thrombosis that was treated a year ago wants to use birth control pill.
Which of the following contraceptive pills would best suit her?
A. Levonorgestrel (progestrone only pills)
B. Ethinyl estradiol/etonogestrel
C. Ethinyl estradiol/norethindrone
D. Ethinyl estradiol/norelgestromin
The correct answer is A. Levonorgestrel (progesterone-only pills).
Explanation:
1. Thromboembolism Risk and Estrogen
Estrogen-Containing Contraceptives: Ethinyl estradiol (found in options B, C, and D) increases the hepatic synthesis of clotting factors (factors II, VII, IX, X, and fibrinogen) and decreases antithrombin III, significantly increasing the risk of venous thromboembolism (VTE).
According to the WHO and CDC Medical Eligibility Criteria for Contraceptive Use, a personal history of deep vein thrombosis (DVT) is a Category 4 contraindication (unacceptable health risk) for combined hormonal contraceptives containing estrogen.
2. Safety of Progestin-Only Pills (POPs)
Progesterone-Only Pills (POPs) such as Levonorgestrel, desogestrel, or norethindrone do not contain estrogen and do not significantly alter baseline coagulation factors or increase the risk of recurrent VTE.
Therefore, progestin-only contraceptives are classified as Category 2 (advantages generally outweigh risks) or Category 1 (no restriction) for women with a history of VTE who are not currently on anticoagulation.
Why Other Options Are Incorrect:
B. Ethinyl estradiol/etonogestrel: Vaginal ring containing ethinyl estradiol (estrogen); contraindicated due to VTE history.
C. Ethinyl estradiol/norethindrone: Combined oral contraceptive pill containing ethinyl estradiol (estrogen); contraindicated due to VTE history.
D. Ethinyl estradiol/norelgestromin: Transdermal patch containing ethinyl estradiol (estrogen); contraindicated due to VTE history.
Exam pearl
History of DVT → avoid estrogen-containing contraceptives when possible; consider a progestin-only pill or other suitable non-estrogen method.
The levonorgestrel intrauterine device (IUD) and implant are also options to discuss with a clinician. The best choice depends on whether the DVT was provoked, the risk of recurrence, and whether the patient is currently receiving anticoagulation.
A patient with DM type 2, with uncontrolled (high) blood glucose for years. The patient complains of burning and stabbing pain in his extremities started for years. Which of the following types of pain this patient is experiencing?
A. Acute pain B. Costochondritis C. Neuropathic pain D. Inflammatory pain
The correct answer is C. Neuropathic pain.
Explanation:
Neuropathic Pain: Caused by damage, lesion, or dysfunction affecting the somatosensory nervous system. Long-term, poorly controlled diabetes mellitus leads to microvascular damage to nerve fibers, resulting in diabetic peripheral neuropathy. Patients classically describe this type of pain as "burning," "stabbing," "shooting," "electric shock-like," or accompanied by "numbness and tingling" in a glove-and-stocking distribution.
Why the Other Options Are Incorrect:
A. Acute pain: Acute pain is sudden, short-lived, and usually caused by a specific injury or tissue trauma (e.g., surgical incision, fracture). This patient's pain has been ongoing for years, making it chronic.
B. Costochondritis: Inflammation of the cartilage that connects a rib to the sternum (breastbone), presenting as localized chest wall pain, not extremity pain.
D. Inflammatory pain: Caused by tissue damage and activation of nociceptors by inflammatory mediators (e.g., arthritis, abscess, surgical wound), rather than direct nerve injury/dysfunction.
Exam pearl:
Burning, shooting, tingling, or electric-shock-like pain in a patient with longstanding diabetes strongly suggests neuropathic pain.
A woman is pregnant in her third trimester. Which of the following vaccines can she receive?
A. Influenza
B. Varicella
C. MMR
D. Rota
The correct answer is A. Influenza.
Explanation:
Safety of Inactivated Vaccines in Pregnancy
Inactivated Influenza Vaccine (IIV): Safe and strongly recommended for pregnant women during any trimester (including the third trimester). Pregnancy increases the risk of severe complications from influenza, and maternal vaccination provides passive immunity (protective antibodies) to the newborn after birth.
Why Other Options Are Contraindicated:
B. Varicella: A live attenuated vaccine. Live vaccines carry a theoretical risk of viral transmission to the fetus and are strictly contraindicated during pregnancy. Women should receive varicella vaccination prior to pregnancy or postpartum.
C. MMR (Measles, Mumps, Rubella): A live attenuated vaccine. Contraindicated during pregnancy due to the risk of congenital rubella syndrome or fetal harm. Postpartum administration is recommended if non-immune.
D. Rota (Rotavirus): A live attenuated oral vaccine administered strictly to infants (starting at 6 to 8 weeks of age) and is not indicated or administered to adults or pregnant women.
Exam pearl:
During pregnancy, inactivated influenza vaccine and Tdap are routinely recommended. Live vaccines such as MMR and varicella should generally be avoided until after pregnancy
A 60-year-old man with 6-year history of myocardial infarction and gout. He presented to the clinic complain of severe pain in his first left consistent with acute gout flare. He mentions that he can't colchicine. What is the most appropriate pharmacotherapy recommendation for his acute flare-associated pain?
A. Ibuprofen
B. Allopurinol
C. Indomethacin
D. Acetaminophen
The most appropriate option among the choices provided is D. Acetaminophen (with important clinical caveats regarding gold-standard therapy) - it is not the preferred treatment for an acute gout flare.
Clinical Breakdown & Explanation
1. Why NSAIDs (A & C) are Contraindicated
History of Myocardial Infarction: Both Ibuprofen (A) and Indomethacin (C) are non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are contraindicated (or carry black-box warnings) in patients with established cardiovascular disease or a history of myocardial infarction because they increase the risk of recurrent thrombotic events, heart failure exacerbations, and renal dysfunction.
Indomethacin carries particularly high cardiovascular and GI risks.
2. Why Allopurinol (B) is Incorrect for Acute Flare Pain
Allopurinol is a xanthine oxidase inhibitor used for chronic urate-lowering therapy (ULT), not for acute analgesia. Initiating or adjusting allopurinol during an acute flare without anti-inflammatory coverage does not treat the acute pain and can actually exacerbate or prolong the flare due to sudden shifts in serum uric acid levels.
3. Role of Acetaminophen (D)
While systemic corticosteroids (e.g., oral prednisone or intra-articular steroid injection) are the true first-line guideline recommendation for an acute gout flare in a patient who cannot take colchicine and has contraindications to NSAIDs (cardiovascular disease/MI history), Acetaminophen is the safest analgesic among the options listed for symptomatic pain relief without increasing cardiovascular risk.
Summary of First-Line Clinical Guidelines
In actual clinical practice, for a patient with an acute gout flare, colchicine intolerance, and cardiovascular disease/history of MI:
Oral Corticosteroids (e.g., Prednisone) or Intra-articular Corticosteroid Injection are the preferred gold-standard first-line treatments.
Among the provided multiple-choice options, Acetaminophen is selected because NSAIDs (Ibuprofen, Indomethacin) are dangerous in ischemic heart disease, and Allopurinol does not treat acute pain.
Exam pearl: Acute gout with a history of MI and inability to take colchicine → consider a corticosteroid rather than an NSAID when clinically appropriate.
Question-writing note: If this is intended as a single-best-answer exam question, consider adding a corticosteroid option. With the current choices, acetaminophen is the least problematic for cardiovascular safety, but it is not the ideal anti-inflammatory treatment.
Which of the following resources is best to use for common compounding techniques and ingredients?
A. Red book
B. Drug facts and comparison
C. Martindale: the complete drug reference
D. Remington: the science and practice of pharmacy
The correct answer is D. Remington: The Science and Practice of Pharmacy.
Explanation:
Remington: The Science and Practice of Pharmacy: Recognized as the definitive reference for pharmaceutics, drug formulation, stability, physical pharmacy, and compounding techniques and ingredients. It provides comprehensive information on compounding calculations, vehicle properties, solubility, and preparation methods for various dosage forms.
Why the Other Options Are Incorrect:
A. Red Book: Used primarily for drug pricing, product availability, national drug codes (NDCs), and manufacturer contact information.
B. Drug Facts and Comparisons: A clinical reference used for comparing therapeutic equivalence, drug interactions, indication guidelines, and detailed drug monograph comparisons.
C. Martindale: The Complete Drug Reference: An international drug reference providing detailed information on drugs used globally, including investigational drugs, herbals, and proprietary preparations worldwide, rather than detailed compounding instructions.
A 28-year-old woman presents with tachycardia and palpitations (ventricular ectopic beats). History revealed essential hypertension and asthma. Patient wants to conceive(mean become pregnant)
Blood pressure 147/98 mmHg
What is the most likely alternative to the β-blocker in terms of efficacy on pressure, heart rate and relative safety?
A. Prazosin B. Enalapril C. Diltiazem D. Methyldopa
The correct answer is C. Diltiazem.
Explanation:
Direct Hemodynamic Analogy: Non-dihydropyridine calcium channel blockers (specifically diltiazem and verapamil) are the primary alternatives to beta-blockers when a similar hemodynamic effect is needed.
Heart Rate & Blood Pressure: Like beta-blockers, diltiazem exhibits negative inotropic (reduces heart contractility) and negative chronotropic (lowers heart rate) properties by blocking L-type calcium channels in cardiac tissue and vascular smooth muscle. This leads to both blood pressure reduction and heart rate control.
Relative Safety profile: Diltiazem is commonly substituted for beta-blockers in patients who have contraindications to beta-blockers, such as asthma, severe COPD, or active peripheral artery disease, offering a safe alternative for rate control and blood pressure management.
Patient-Specific Indications & Contraindications:
Asthma: Non-selective and even cardioselective beta-blockers (at higher doses) can trigger bronchospasm in patients with asthma. Diltiazem causes no airway constriction and is safe in asthmatic patients.
Pregnancy Planning: Enalapril (an ACE inhibitor) is strictly contraindicated in women planning to conceive due to severe teratogenicity and fetotoxicity. Diltiazem is safer in this context compared to ACE inhibitors/ARBs.
Why the Other Options Are Incorrect:
A. Prazosin: An alpha_1-adrenergic blocker that lowers blood pressure via vasodilation, but it does not lower heart rate (it can actually cause reflex tachycardia).
B. Enalapril: An ACE inhibitor that lowers blood pressure but does not slow heart rate or control arrhythmias. Furthermore, ACE inhibitors are teratogenic (Category D) and strictly contraindicated in pregnancy or preconception.
D. Methyldopa: A centrally acting alpha_2-agonist used primarily in pregnancy; it is not considered a primary or standard alternative to beta-blockers for general hypertension or heart rate control due to significant side effects (e.g., sedation, hemolytic anemia, hepatotoxicity).
Exam pearl: Diltiazem and verapamil can provide both blood-pressure and heart-rate control. However, they should generally be avoided in patients with heart failure with reduced ejection fraction and used cautiously with β-blockers because of the risk of bradycardia and AV block.
Disclaimer: These seven Clinical Pharmacy MCQs are intended for educational purposes and pharmacy exam preparation. They cover cardiovascular pharmacology, amiodarone monitoring, contraception after DVT, diabetic neuropathic pain, vaccination during pregnancy, acute gout management, and pharmaceutical compounding. Answers and explanations are provided to support learning for PharmD students, pharmacists, and candidates preparing for NAPLEX, DHA, MOH, Prometric, PEBC, and other licensing examinations.
Clinical decisions should always be based on current clinical guidelines, reliable drug information resources, and individual patient assessment.
For more pharmacy MCQs, clinical pearls, and exam-preparation resources, visit seenqaaf.blogspot.com and follow PharmaAssist on Facebook.
0 Comments